Early Onset and Progression of Left Ventricular Remodeling After Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy
暂无分享,去创建一个
M. Götte | C. Visser | J. Twisk | F. T. ten Cate | J. T. ten Berg | A. Beek | M. Hofman | W. V. van Dockum | O. Bondarenko | A. V. van Rossum
[1] W. Schill. Applied Longitudinal Data Analysis for Epidemiology: A Practical Guide. , 2004 .
[2] A. van Rossum,et al. Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging. , 2004, Journal of the American College of Cardiology.
[3] R. Kim,et al. How we perform delayed enhancement imaging. , 2003, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[4] Mario J. Garcia,et al. Comparison of left ventricular diastolic function in obstructive hypertrophic cardiomyopathy in patients undergoing percutaneous septal alcohol ablation versus surgical myotomy/myectomy. , 2003, The American journal of cardiology.
[5] J. Veselka,et al. Early remodelling of left ventricle and improvement of myocardial performance in patients after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy. , 2003, International journal of cardiology.
[6] Dudley J Pennell,et al. Assessment of Left Ventricular Mass by Cardiovascular Magnetic Resonance , 2002, Hypertension.
[7] N. Smedira,et al. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery. , 2002, Journal of the American College of Cardiology.
[8] U. Sigwart,et al. New concepts in hypertrophic cardiomyopathies, part II. , 2001, Circulation.
[9] RobertRoberts,et al. New Concepts in Hypertrophic Cardiomyopathies, Part II , 2001 .
[10] A. Knez,et al. Pressure-guided nonsurgical myocardial reduction induced by small septal infarctions in hypertrophic obstructive cardiomyopathy. , 2001, Journal of the American College of Cardiology.
[11] J. Plana,et al. Efficacy of nonsurgical septal reduction therapy in symptomatic patients with obstructive hypertrophic cardiomyopathy and provocable gradients. , 2001, The American journal of cardiology.
[12] R. Kim,et al. Visualization of presence, location, and transmural extent of healed Q-wave and non–Q-wave myocardial infarction , 2001 .
[13] M. Entman,et al. Decreased Expression of Tumor Necrosis Factor-&agr; and Regression of Hypertrophy After Nonsurgical Septal Reduction Therapy for Patients With Hypertrophic Obstructive Cardiomyopathy , 2001, Circulation.
[14] S. Nagueh,et al. Regression of Left Ventricular Hypertrophy After Nonsurgical Septal Reduction Therapy for Hypertrophic Obstructive Cardiomyopathy , 2001, Circulation.
[15] Edwin Wu,et al. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction , 2001, The Lancet.
[16] J. K. Dunn,et al. Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: one-year follow-up. , 2000, Journal of the American College of Cardiology.
[17] J. Schulz-Menger,et al. The value of magnetic resonance imaging of the left ventricular outflow tract in patients with hypertrophic obstructive cardiomyopathy after septal artery embolization. , 2000, Circulation.
[18] L. Faber,et al. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first series of 25 patients , 2000, Heart.
[19] A. Marian. Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy , 2000, The Lancet.
[20] M. Henein,et al. Electromechanical left ventricular behavior after nonsurgical septal reduction in patients with hypertrophic obstructive cardiomyopathy. , 1999, Journal of the American College of Cardiology.
[21] S. Nagueh,et al. Changes in left ventricular diastolic function 6 months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. , 1999, Circulation.
[22] U. Gleichmann,et al. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography. , 1998, Circulation.
[23] M. Verani,et al. Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy. , 1998, Circulation.
[24] D. Fassbender,et al. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients. , 1998, Journal of the American College of Cardiology.
[25] L. Fananapazir,et al. Therapeutic options in patients with obstructive hypertrophic cardiomyopathy and severe drug-refractory symptoms. , 1998, Journal of the American College of Cardiology.
[26] B. Everitt,et al. Analysis of longitudinal data , 1998, British Journal of Psychiatry.
[27] D. Harrington,et al. Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients. , 1997, Circulation.
[28] U. Sigwart. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy , 1995, The Lancet.
[29] O. Henriksen,et al. Reproducibility of cardiac volume measurements including left ventricular mass determined by MRI. , 1993, Clinical physiology.
[30] Tapabrata Maiti,et al. Analysis of Longitudinal Data (2nd ed.) (Book) , 2004 .
[31] O. Simonetti,et al. An improved MR imaging technique for the visualization of myocardial infarction. , 2001, Radiology.